Study of medianism for the cell growth inhibition by HB-EGF in cardiac valve development
HB-EGF抑制心脏瓣膜发育中细胞生长的中位作用研究
基本信息
- 批准号:18570176
- 负责人:
- 金额:$ 2.57万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
HB-EGF is a member of the EGF family of growth factors that has a high affinity for heparin and heparan sulfate (HS), and is known to be involved in cardiac valve development. HB-EGF suppresses proliferation of mesenchymal cells in this process. In this research, we investigated the regulatory mechanisms involved in the HB-EGF-induced cell growth inhibition in cardiac valve development (valvulogenesis).1) Significance of the interaction of HB-EGF with HS-proteoglycans (HSPGs) in valvulogenesis. We generated the knock-in mice expressing a heparin-binding domain-truncated form (HB^<Δbb>) of the molecule, which lacks HS-binding activity. HB^<Δbb/Δbb> mice developed enlarged cardiac valves with abnormal hyperproliferation of the mesenchymal cells during valvulogenesis, phenotypes similar to that in HB-EGF null (HB^<dcl/del>) mice. In vitro study using endocardial cushion explants culture demonstrated requirement of HB-EGF-HSPGs interaction for HB-EGF-EGFR signal-mediated growth-inhibition … More of mesenchymal cells. These results indicate that interaction of HB-EGF with HSPGs promotes growth-inhibition of differentiated mesenchymal cells in developing cardiac valve. (Manuscript in preparation)2) HB-EGF and Snail signaling negatively regulates proliferation of mesenchymal cells during valvulogenesis. We found that the expression of Snail was dramatically decreased in HB^<del/del> mutant valves during remodeling process in valvulogenesis. Exogenously introduced Snail and HB-EGF into the HB^<del/del> mutant valves were able to rescue the overproliferation of mesenchymal cells. These results demonstrate that HB-EGF inhibits proliferation of mesenchymal cells via Snail during valve remodeling. (Manuscript in preparation)3) Perinatal distal lung development: another physiological process in which HB-EGF induces cell growth inhibition. HB^<del/del> newborns displayed abnormally thick alveolar walls, occurring from E18.5, that reduced the terminal saccular space area, with a increase in cell proliferation, indicating that HB-EGF suppresses distal lung cell proliferation. Furthermore, an analysis of alveolar morphology and proliferation in HB-EGF and TGFα double mutant newborns revealed that HB-EGF and TGFa function synergistically in this suppression. Crosses between HB^<del/del> mice and waved 2 mice, a hypomorphic EGFR mutant strain, suggest that HB-EGF and EGFR cooperate in this process. Thus, HB-EGF has a suppressive function that contributes to decelerating distal lung cell proliferation synergistically with TGFa through EGFR in perinatal distal lung development. (Dev. Dyn. 2008, 237, 247-258) Less
HB-EGF 是 EGF 生长因子家族的成员,对肝素和硫酸乙酰肝素 (HS) 具有高亲和力,已知 HB-EGF 参与心脏瓣膜发育,在此过程中抑制间充质细胞的增殖。在本研究中,我们研究了心脏瓣膜发育(瓣膜形成)中 HB-EGF 诱导的细胞生长抑制所涉及的调节机制。1) HB-EGF 与瓣膜形成中的 HS 蛋白聚糖 (HSPG) 我们生成了表达该分子的肝素结合结构域截短形式 (HB^<Δbb>) 的敲入小鼠,该分子缺乏 HB^<Δbb/Δbb> 结合活性。小鼠心脏瓣膜增大,瓣膜形成过程中间充质细胞异常过度增殖,表型与 HB-EGF null 相似(HB^<dcl/del>) 小鼠。使用心内膜垫外植体培养的体外研究表明,HB-EGF-HSPG 相互作用对于 HB-EGF-EGFR 信号介导的间充质细胞的生长抑制是必需的。 HB-EGF 与 HSPG 促进心脏瓣膜发育中分化间充质细胞的生长抑制(手稿正在准备中)2) HB-EGF 和 Snail 信号负向。在瓣膜形成过程中调节间充质细胞的增殖我们发现,在瓣膜形成的重塑过程中,HB^<del/del>突变瓣膜中Snail的表达显着降低。突变瓣膜能够挽救间充质细胞的过度增殖。这些结果表明,HB-EGF 在瓣膜重塑过程中通过 Snail 抑制间充质细胞的增殖。 (手稿准备中)3)围产期远端肺发育:HB-EGF 诱导细胞生长抑制的另一个生理过程,HB^<del/del> 新生儿表现出异常厚的肺泡壁,发生于 E18.5,从而减少了终末囊泡。空间区域,细胞增殖增加,表明 HB-EGF 抑制远端肺细胞增殖。此外,对 HB-EGF 和 TGFα 双突变新生儿的肺泡形态和增殖进行分析。揭示HB-EGF和TGFα在该抑制中协同作用。HB^<del/del>小鼠和waved 2小鼠(一种低效型EGFR突变株)之间的杂交表明HB-EGF和EGFR在该过程中协同作用。 EGF 具有抑制功能,在围产期远端肺发育中通过 EGFR 与 TGFa 协同减缓远端肺细胞增殖 (Dev.动态 2008, 237, 247-258) 少
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
HB-EGF is required for normal lung morphogenesis during canalicular stage.
HB-EGF 是小管阶段正常肺形态发生所必需的。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:南 誠剛
- 通讯作者:南 誠剛
KB-EGF decelerates cell proliferation synergistically with TGFα in perinatal distal lung development.
KB-EGF 与围产期远端肺发育中的 TGFα 协同减缓细胞增殖。
- DOI:
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Minami; S.; et. al.
- 通讯作者:et. al.
ErbB and HB-EGF signaling in heart development and function.
ErbB 和 HB-EGF 信号在心脏发育和功能中的作用。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Iwamoto; R.; et. al.
- 通讯作者:et. al.
Maternal heparin-binding-EGF deficiency limits pregnancy success in mice.
母体肝素结合 EGF 缺乏限制了小鼠的妊娠成功率。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Xie; H.; et. al.
- 通讯作者:et. al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IWAMOTO Ryo其他文献
IWAMOTO Ryo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IWAMOTO Ryo', 18)}}的其他基金
Inhibition of cell proliferation by induction of HB-EGF-HSPG-ErbB4 signaling system
通过诱导 HB-EGF-HSPG-ErbB4 信号系统抑制细胞增殖
- 批准号:
18K06218 - 财政年份:2018
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulation of cell proliferation by HB-EGF in mouse cardiac valve development
HB-EGF 对小鼠心脏瓣膜发育中细胞增殖的调节
- 批准号:
20570183 - 财政年份:2008
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Physiological function of HB-EGF : Study of the knock-in mice of the mutant form of HB-EGF
HB-EGF的生理功能:HB-EGF突变体敲入小鼠的研究
- 批准号:
12680705 - 财政年份:2000
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study of the activity of proHB-EGF complex.
proHB-EGF复合物活性的研究。
- 批准号:
09680706 - 财政年份:1997
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
DARPP-32促进EGFR:ERBB3二聚体形成介导转移性肺腺癌吉非替尼耐药的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:54.7 万元
- 项目类别:面上项目
人类表皮生长因子受体II(ERBB2)基因高频热点突变介导膀胱尿路上皮癌进展的分子机制研究
- 批准号:81802827
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
非编码长链RNA-LOC102723323调控乳腺癌细胞ERBB3表达的分子机制研究
- 批准号:81802625
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
靶向CACYBP活化RNF41/ErbB3通路抑制肝癌生长的分子机制及其潜在应用
- 批准号:81872006
- 批准年份:2018
- 资助金额:58.0 万元
- 项目类别:面上项目
UCA1/miR-125a-3p轴向调控ErbB3参与NSCLC的EGFR-TKI获得性耐药机制
- 批准号:81702243
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
ErbB4の部位特異的糖鎖解析による糖鎖機能の解明
通过 ErbB4 的位点特异性聚糖分析阐明聚糖功能
- 批准号:
21K06083 - 财政年份:2021
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
SCAMP3 as a regulator of EGFR/STAT3 axis in triple-negative breast cancer
SCAMP3 作为三阴性乳腺癌 EGFR/STAT3 轴的调节因子
- 批准号:
10643857 - 财政年份:2021
- 资助金额:
$ 2.57万 - 项目类别:
SCAMP3 as a regulator of EGFR/STAT3 axis in triple-negative breast cancer
SCAMP3 作为三阴性乳腺癌 EGFR/STAT3 轴的调节因子
- 批准号:
10408726 - 财政年份:2021
- 资助金额:
$ 2.57万 - 项目类别:
SCAMP3 as a regulator of EGFR/STAT3 axis in triple-negative breast cancer
SCAMP3 作为三阴性乳腺癌 EGFR/STAT3 轴的调节因子
- 批准号:
10202866 - 财政年份:2021
- 资助金额:
$ 2.57万 - 项目类别:
Stress responses drive resistance and shape tumor evolution in EGFR mutant lung cancer
应激反应驱动EGFR突变肺癌的耐药性并塑造肿瘤进化
- 批准号:
10329992 - 财政年份:2020
- 资助金额:
$ 2.57万 - 项目类别: